Soligenix, Inc. (SNGX): Price and Financial Metrics

Soligenix, Inc. (SNGX): $0.69

0.05 (-6.41%)

POWR Rating

Component Grades








SNGX Price/Volume Stats

Current price $0.69 52-week high $10.35
Prev. close $0.74 52-week low $0.38
Day low $0.63 Volume 405,500
Day high $0.74 Avg. volume 778,892
50-day MA $0.53 Dividend yield N/A
200-day MA $0.98 Market Cap 7.14M

SNGX Stock Price Chart Interactive Chart >


  • Growth is the dimension where SNGX ranks best; there it ranks ahead of 73.7% of US stocks.
  • The strongest trend for SNGX is in Sentiment, which has been heading up over the past 62 days.
  • SNGX's current lowest rank is in the Stability metric (where it is better than 2.19% of US stocks).

SNGX Stock Summary

  • SNGX has a market capitalization of $7,576,114 -- more than approximately just 4.54% of US stocks.
  • With a year-over-year growth in debt of -69.01%, SOLIGENIX INC's debt growth rate surpasses only 3.05% of about US stocks.
  • In terms of volatility of its share price, SNGX is more volatile than 96.61% of stocks we're observing.
  • Stocks that are quantitatively similar to SNGX, based on their financial statements, market capitalization, and price volatility, are FBIO, BTAI, MEIP, TVTX, and PALI.
  • Visit SNGX's SEC page to see the company's official filings. To visit the company's web site, go to

SNGX Valuation Summary

  • SNGX's price/sales ratio is 4.7; this is 23.68% higher than that of the median Healthcare stock.
  • SNGX's price/earnings ratio has moved up 3.7 over the prior 243 months.

Below are key valuation metrics over time for SNGX.

Stock Date P/S P/B P/E EV/EBIT
SNGX 2023-11-20 4.7 1.1 -0.6 0.3
SNGX 2023-11-17 4.4 1.0 -0.5 0.3
SNGX 2023-11-16 4.4 1.0 -0.5 0.3
SNGX 2023-11-15 4.7 1.1 -0.6 0.3
SNGX 2023-11-14 4.5 1.0 -0.5 0.3
SNGX 2023-11-13 4.5 1.0 -0.5 0.3

SNGX Growth Metrics

    Its 3 year price growth rate is now at -46.22%.
  • The 3 year cash and equivalents growth rate now stands at 217.71%.
  • Its 4 year cash and equivalents growth rate is now at 0.83%.
Over the past 15 months, SNGX's revenue has gone down $433,526.

The table below shows SNGX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.858496 -12.07723 -14.74866
2022-06-30 0.878554 -11.86238 -15.02721
2022-03-31 0.864738 -10.99324 -14.53752
2021-12-31 0.824268 -11.73962 -12.55097
2021-09-30 0.869409 -12.80922 -13.38736
2021-06-30 1.292022 -12.76004 -11.58997

SNGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNGX has a Quality Grade of F, ranking ahead of 4.48% of graded US stocks.
  • SNGX's asset turnover comes in at 0.055 -- ranking 317th of 682 Pharmaceutical Products stocks.
  • AVDL, OTIC, and ICPT are the stocks whose asset turnover ratios are most correlated with SNGX.

The table below shows SNGX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.055 0.261 -2.934
2021-03-31 0.082 0.296 -9.045
2020-12-31 0.171 0.228 13.842
2020-09-30 0.253 0.205 4.321
2020-06-30 0.353 0.185 4.346
2020-03-31 0.502 0.213 4.558

SNGX Price Target

For more insight on analysts targets of SNGX, see our SNGX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.88 Average Broker Recommendation 1.75 (Moderate Buy)

Soligenix, Inc. (SNGX) Company Bio

Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.

SNGX Latest News Stream

Event/Time News Detail
Loading, please wait...

SNGX Latest Social Stream

Loading social stream, please wait...

View Full SNGX Social Stream

Latest SNGX News From Around the Web

Below are the latest news stories about SOLIGENIX INC that investors may wish to consider to help them evaluate SNGX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning!

William White on InvestorPlace | December 1, 2023

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that an article describing the potential use of HyBryte™ in the treatment of cutaneous T-cell lymphoma (CTCL) has been published in Frontiers in Drug Discovery. The mini-review summarizes findings about the use, mechanism and effectiveness of HyBryte™ in the treatment of CT

Yahoo | December 1, 2023

Jefferies Is Pounding the Table on Snap (SNAP) Stock

Snap stock is heading higher on Thursday after the social media company's shares were upgraded to a 'buy' rating by Jefferies analysts.

William White on InvestorPlace | November 30, 2023

TSLA Stock Alert: The Tesla Cybertruck Launches Today

Tesla stock is on the move Thursday as investors in TSLA shares prepare for the official Cybertruck launch event taking place today!

William White on InvestorPlace | November 30, 2023

Why Is Soligenix (SNGX) Stock Up 285% Today?

Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.

William White on InvestorPlace | November 30, 2023

Read More 'SNGX' Stories Here

SNGX Price Returns

1-mo 65.87%
3-mo 38.00%
6-mo -3.50%
1-year -91.21%
3-year -98.07%
5-year -95.53%
YTD -89.82%
2022 -31.55%
2021 -48.41%
2020 -11.72%
2019 68.60%
2018 -61.26%

Continue Researching SNGX

Want to see what other sources are saying about Soligenix Inc's financials and stock price? Try the links below:

Soligenix Inc (SNGX) Stock Price | Nasdaq
Soligenix Inc (SNGX) Stock Quote, History and News - Yahoo Finance
Soligenix Inc (SNGX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!